Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Individuals with self-reported moderate to severe psoriatic arthritis (PsA) face a higher disease burden, particularly among ...

Alex Thompson CFA, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Oruka Therapeutics (ORKA). Alex Thompson CFA has given ...

InnoCare Pharma has announced that its Phase II clinical study of the Tyrosine Kinase 2 (TYK2) inhibitor ICP-488 for ...

InnoCare Pharma’s tyrosine kinase 2 (TYK2) inhibitor has hit the main goals of a phase 2 trial in China, sustaining the ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that phase II clinical study results of ...

These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.

Some only have mild itchiness, while others are so itchy that they ... If your skin doesn’t respond to at-home treatments, or the eczema or psoriasis exhibit more aggressive symptoms than ever before, ...

Dermatologists recently have developed and validated several tools for assessing itch in plaque psoriasis, such as the Peak ...

Protopic (tacrolimus) and Elidel (pimecrolimus) are approved by the FDA for the treatment of eczema but are regularly used off-label to treat all forms of psoriasis. Side effects tend to be mild and ...

The following is a summary of “Risk of fungal infection in patients with psoriasis receiving biologics: a retrospective single-center cohort study,” published in the September 2024 issue of ...